Showing results (1-10 of 182) with videos related to
Sort By:
Pageof 19
3D Printing and Additive Manufacturing|March 28, 2025
Predicting Linear Dimensional Accuracy of Material Extrusion Parts in Dependence of Process Parameters Using Neural Networks Optimized by an Evolutionary AlgorithmCarsten Schmidt, Jonas Funk, Rainer Griesbaum, et al.Frontiers in Plant Science|April 2, 2025
Bridging technology and ecology: enhancing applicability of deep learning and UAV-based flower recognitionMarie Schnalke, Jonas Funk, Andreas WagnerJournal of Molecular Biology|January 8, 2008
Apparent homomeric NR1 currents observed in Xenopus oocytes are caused by an endogenous NR2 subunitCarsten Schmidt, Michael HollmannMolecular and Cellular Neurosciences|June 16, 2009
Molecular and functional characterization of Xenopus laevis N-methyl-d-aspartate receptorsCarsten Schmidt, Michael HollmannExpert Review of Gastroenterology & Hepatology|November 22, 2015
Vedolizumab for the treatment of ulcerative colitisAndreas Stallmach, Carsten Schmidt, Niels TeichMolecular Pharmacology|October 11, 2005
Revisiting the postulated "unitary glutamate receptor": electrophysiological and pharmacological analysis in two heterologous expression systems fails to detect evidence for its existenceCarsten Schmidt, Markus Werner, Michael HollmannDigestive Diseases (Basel, Switzerland)|November 10, 2009
Malignant transformation in inflammatory bowel disease - surveillance guideAndreas Stallmach, Christiane Bielecki, Carsten SchmidtJournal of Crohn'S & Colitis|June 21, 2011
Depression and mucosal proinflammatory cytokines are associated in patients with ulcerative colitis and pouchitis - A pilot studyWinfried Häuser, Carsten Schmidt, Andreas StallmachMaterials (Basel, Switzerland)|July 12, 2025
Influence of Surface Treatments and Adhesive Type on Bond Strength Between Stainless Steel and CFRP in Agricultural MachineryLeif Steuernagel, Carsten Schmidt, Christian JenenschJournal of Clinical Gastroenterology|February 4, 2020
Comparative Analysis of 3-Year Persistence With Vedolizumab Compared With Antibodies Against Tumor Necrosis Factor-Alpha in Patients With Inflammatory Bowel Disease in Germany: Retrospective Analysis of a Large Prescription DatabaseUlf Helwig, Karel Kostev, Carsten SchmidtPageof 19